{"id":6018,"date":"2026-07-18T11:23:12","date_gmt":"2026-07-18T11:23:12","guid":{"rendered":"https:\/\/knight-pharma.com\/web\/?page_id=6018"},"modified":"2026-07-18T11:23:12","modified_gmt":"2026-07-18T11:23:12","slug":"kpi-enrozin","status":"publish","type":"page","link":"https:\/\/knight-pharma.com\/web\/kpi-enrozin\/","title":{"rendered":"KPI ENROZIN"},"content":{"rendered":"
\n
\"\"<\/figure>\n<\/div>\n\n\n

COMPOSITION<\/mark><\/strong>
Each ml contains:
Enrofloxacin ………………………………………………….. 100 mg
Tylosin tartrate ……………………………………………… 50 mg
Excipients ad …………………………………………………. 1 ml<\/p>\n\n\n\n

INDICATIONS<\/mark><\/strong>
For the treatment of gastrointestinal and respiratory infections caused by organisms susceptible to enrofloxacin and tylosin, including\u00a0Campylobacter, Mycoplasma, Pasteurella, Staphylococcus, Streptococcus, Treponema<\/em>\u00a0spp., and\u00a0Mannheimia haemolytica<\/em>\u00a0in calves, cattle, goats, sheep, and swine.<\/p>\n\n\n\n

ADMINISTRATION AND DOSAGE<\/mark><\/strong>
For intramuscular administration.
Administer\u00a01 ml per 20 kg body weight<\/strong>\u00a0once daily for\u00a03\u20135 days<\/strong>.<\/p>\n\n\n\n

CONTRAINDICATIONS<\/mark><\/strong>
Hypersensitivity to tylosin or enrofloxacin.
Do not administer concurrently with penicillins, cephalosporins, quinolones, or cycloserine.<\/p>\n\n\n\n

SIDE EFFECTS<\/mark><\/strong>
Local reactions at the injection site may occur and usually resolve within a few days.
Diarrhea, epigastric pain, and skin sensitization may occur.<\/p>\n\n\n\n

WITHDRAWAL PERIOD<\/mark><\/strong>
Meat: 10 days
Milk: 3 days<\/p>\n\n\n\n

STORAGE<\/mark><\/strong>
Store below\u00a030\u202f\u00b0C<\/strong>. Protect from light.<\/p>\n\n\n\n

FOR VETERINARY USE ONLY<\/strong><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

COMPOSITIONEach ml contains:Enrofloxacin ………………………………………………….. 100 mgTylosin tartrate ……………………………………………… 50 mgExcipients ad …………………………………………………. 1 ml INDICATIONSFor the treatment of gastrointestinal and respiratory infections caused by organisms susceptible to enrofloxacin and tylosin, including\u00a0Campylobacter, Mycoplasma, Pasteurella, Staphylococcus, Streptococcus, Treponema\u00a0spp., and\u00a0Mannheimia haemolytica\u00a0in calves, cattle, goats, sheep, and swine. ADMINISTRATION AND DOSAGEFor intramuscular administration.Administer\u00a01 ml …<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-6018","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/comments?post=6018"}],"version-history":[{"count":1,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6018\/revisions"}],"predecessor-version":[{"id":6020,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6018\/revisions\/6020"}],"wp:attachment":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/media?parent=6018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}